Ticker Details
Charles River Laboratories International, Inc. Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$11.04B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.49 | 1.27%
Avg Daily Range (30 D):	$3.99 | 1.98%
Avg Daily Range (90 D):	$3.88 | 2.17%

Institutional Daily Volume
Avg Daily Volume:	.54M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.64M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	37
Avg Trade Size (Sh.) (90 D):	38

Institutional Trades
Total Institutional Trades:	13,752
Avg Institutional Trade:	$4.5M
Avg Institutional Trade (30 D):	$18.23M
Avg Institutional Trade (90 D):	$15.47M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$9.33M
Avg Closing Trade (30 D):	$32.99M
Avg Closing Trade (90 D):	$30.02M
Avg Closing Volume:	59.26K

News

Jul 15, 2026 @ 10:46 AM Global Clinical Trials Market to Reach $176.32 Bil... Source: Researchandmarkets.Com

Jun 18, 2026 @ 5:00 PM Global Cell and Gene Therapy CDMO Market Anticipat... Source: Delveinsight

May 25, 2026 @ 8:15 AM Cell Banking Outsourcing Market: 16%+ CAGR (2026-2... Source: Mordor Intelligence

May 4, 2026 @ 5:00 PM Global Plasmid DNA Manufacturing Market Anticipate... Source: Delveinsight

Apr 28, 2026 @ 5:00 PM Global AAV Vector Manufacturing Market Gearing Up ... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.7	$-.3	$-5.57
Diluted EPS	$-3.7	$-.3	$-5.56
Revenue	$4.03B	$995.83M	$994.23M
Gross Profit
Net Income / Loss	$-182.84M	$-14.8M	$-276.29M
Operating Income / Loss	$70.39M	$119.9M	$-283.44M
Cost of Revenue
Net Cash Flow	$-33.53M	$-17.8M	$6.78M
PE Ratio